Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Graves' disease can cause hair loss in children and should be considered when treating pediatric alopecia areata.

KFSD is a rare condition causing scarring hair loss, with no effective treatment known at the time of the report.

Cetuximab can cause eyelash growth, which is rare but manageable.

A boy with chromosome 13q deletion syndrome developed eye cancer, a woman with breast cancer lost vision due to a rare side-effect of her treatment, a man's vision worsened after using a hair loss drug, and two rare disorders were discussed. Optical Coherence Tomography is useful for diagnosing and monitoring these conditions.

Hair transplants using follicular unit grafting and a strategic design can give great results even for men with severe hair loss.

Low-dose finasteride may cause muscle weakness and eye issues, but stopping the drug can lead to recovery.

JAK inhibitors like tofacitinib can effectively treat severe alopecia areata.

An 8-year-old boy's early puberty was caused by a rare hormone-secreting brain tumor, which was successfully treated with surgery.

Neuropilin 2 may be a biomarker for melanoma and affects melanocyte behavior.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Anti-angiogenic therapy can help treat cancer but may cause resistance and side effects, so alternative methods are being explored.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

Eating 500 fewer calories a day and making lifestyle changes can improve PCOS symptoms and reduce diabetes risk; more research is needed on its causes and treatments.

The document concludes that diagnosing and treating Human African Trypanosomiasis is challenging, but new treatments like fexinidazole are promising.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

TGFβ's manipulation of inflammation and immune cells affects cancer spread, suggesting new treatment strategies and biomarkers.

WNT10A helps esophageal cancer cells spread and keep renewing themselves.

The document concludes that post-menopausal frontal fibrosing alopecia is a poorly understood condition that does not respond well to common treatments.

CGRP may help protect hair follicles from immune system attacks, potentially slowing hair loss.

Some people experience severe, long-lasting side effects from fluoroquinolone antibiotics, leading to the recommendation of limited use and increased awareness of these risks.

A woman with breast cancer developed a rare condition causing excessive fine hair growth on her face and body.

The document concludes that better treatments for CCCA are needed and more research is required to understand its causes related to hairstyling and genetics.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Propranolol can cause reversible hair loss.